Emergent Blog Pure MHC to Participate in Conference On Vaccine Research

Next week, Pure MHC will take part in the annual Immunotherapy & Vaccine Summit (IMVACS) in Boston, which showcases clinical advancement of immune therapies through technology and innovation. Pure MHC will present some of its newest research into targeting cancer cells and the potential therapies that could evolve from it. Dr. William Hildebrand, Chief Scientist [...]The post Pure MHC to Participate in Conference On Vaccine Research appeared first on Emergent Technologies.